Understanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2)

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Al-Karmalawy, A. A., Dahab, M. A., Metwaly, A. M., Elhady, S. S., Elkaeed, E. B., Eissa, I. H., & Darwish, K. M. (2021). Molecular docking and dynamics simulation revealed the potential inhibitory activity of ACEIs against SARS-CoV-2 targeting the hACE2 receptor. Frontiers in Chemistry, 9, 661230. https://doi.org/10.3389/fchem.2021.661230
   PubMed Web of Science ®Google Scholar
• Ali, A., & Vijayan, R. (2020). Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms. Scientific Reports, 10, 14214. https://doi.org/10.1038/s41598-020-71188-3
   PubMed Web of Science ®Google Scholar
• Amin, M., Sorour, M. K., & Kasry, A. (2020). Comparing the binding interactions in the receptor binding domains of SARS-CoV-2 and SARS-CoV. The Journal of Physical Chemistry Letters, 11, 4897–4900. https://doi.org/10.1021/acs.jpclett.0c01064
   PubMed Web of Science ®Google Scholar
• Anonymous (2021). COVID-19 vaccine (D. Harkless (Ed.)). Wikipedia.
   Google Scholar
• Baker, N. A., Sept, D., Joseph, S., Holst, M. J., & McCammon, J. A. (2001). Electrostatics of nanosystems: Application to microtubules and the ribosome. Proceedings of the National Academy of Sciences United States of America, 98, 10037–10041. https://doi.org/10.1073/pnas.181342398
   PubMed Web of Science ®Google Scholar
• Barros, R. O., Junior, F. L., Pereira, W. S., Oliveira, N. M., & Ramos, R. M. (2020). Interaction of drug candidates with various SARS-CoV-2 receptors: An in silico study to combat COVID-19. Journal of Proteome Research, 19, 4567–4575. https://doi.org/10.1021/acs.jproteome.0c00327
   PubMed Web of Science ®Google Scholar
• Ceraolo, C., & Giorgi, F. M. (2020). Genomic variance of the 2019-nCoV coronavirus. Journal of Medical Virology, 92, 522–528. https://doi.org/10.1002/jmv.25700
   PubMed Web of Science ®Google Scholar
• Chand, M., Hopkins, S., Dabrera, G., Achison, C., Barclay, W., Ferguson, N., Volz, E., Loman, N., Rambaut, A., & Barrett, J., 2020. Investigation of novel SARS-COV-2 variant, Variant of Concern 202012/01. Public Health England, United Kingdom, pp. 1–11.
   Google Scholar
• Chen, R. E., Zhang, X., Case, J. B., Winkler, E. S., Liu, Y., VanBlargan, L. A., Liu, J., Errico, J. M., Xie, X., Suryadevara, N., Gilchuk, P., Zost, S. J., Tahan, S., Droit, L., Turner, J. S., Kim, W., Schmitz, A. J., Thapa, M., Wang, D., … Diamond, M. S. (2021). Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nature Medicine, 27, 717–726. https://doi.org/10.1038/s41591-021-01294-w
   PubMed Web of Science ®Google Scholar
• Choi, B., Choudhary, M. C., Regan, J., Sparks, J. A., Padera, R. F., Qiu, X., Solomon, I. H., Kuo, H. H., Boucau, J., Bowman, K., Adhikari, U. D., Winkler, M. L., Mueller, A. A., Hsu, T. Y., Desjardins, M., Baden, L. R., Chan, B. T., Walker, B. D., Lichterfeld, M., … Li, J. Z. (2020). Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. New England Journal of Medicine, 383, 2291–2293. https://doi.org/10.1056/NEJMc2031364
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. (2020a). Clinical trial of efficacy, safety, and immunogenicity of Gam-COVID-Vac vaccine against COVID-19.
   Google Scholar
• ClinicalTrials.gov. (2020b). Clinical trial of recombinant novel coronavirus vaccine (Adenovirus Type 5 Vector) against COVID-19.
   Google Scholar
• ClinicalTrials.gov. (2020c). Safety and immunogenicity study of inactivated vaccine for prevention of SARS-CoV-2 infection (COVID-19) (Renqiu).
   Google Scholar
• ClinicalTrials.gov. (2020d). Study to describe the safety, tolerability, immunogenicity, and efficacy of RNA vaccine candidates against COVID-19 in healthy adults.
   Google Scholar
• ClinicalTrials.gov. (2020e). A study to evaluate efficacy, safety, and immunogenicity of mRNA-1273 vaccine in adults aged 18 years and older to prevent COVID-19.
   Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. Journal of Chemical Physics, 98, 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• de Andrade, J., Gonçalves, P. F. B., & Netz, P. A. (2020). Why does the novel coronavirus spike protein interact so strongly with the human ACE2? A thermodynamic answer. ChemBioChem, 22, 865–875. https://doi.org/10.1002/cbic.202000455
   PubMed Web of Science ®Google Scholar
• de Oliveira, O. V., Rocha, G. B., Paluch, A. S., & Costa, L. T. (2021). Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening. Journal of Biomolecular Structure and Dynamics, 11, 3924–3933 https://doi.org/10.1080/07391102.2020.1772885
   Google Scholar
• De Vries, S. J., Van Dijk, M., & Bonvin, A. M. (2010). The HADDOCK web server for data-driven biomolecular docking. Nature Protocols, 5, 883. https://doi.org/10.1038/nprot.2010.32
   PubMed Web of Science ®Google Scholar
• Dominguez, C., Boelens, R., & Bonvin, A. M. (2003). HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. Journal of the American Chemical Society, 125, 1731–1737. https://doi.org/10.1021/ja026939x
   PubMed Web of Science ®Google Scholar
• Duan, Y., Wu, C., Chowdhury, S., Lee, M. C., Xiong, G., Zhang, W., Yang, R., Cieplak, P., Luo, R., Lee, T., Caldwell, J., Wang, J., & Kollman, P. (2003). A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. Journal of Computational Chemistry, 24, 1999–2012. https://doi.org/10.1002/jcc.10349
   PubMed Web of Science ®Google Scholar
• Ekins, S., Mottin, M., Ramos, P. R., Sousa, B. K., Neves, B. J., Foil, D. H., Zorn, K. M., Braga, R. C., Coffee, M., & Southan, C. (2020). Déjà vu: Stimulating open drug discovery for SARS-CoV-2. Drug Discovery Today, 25, 928–941. https://doi.org/10.1016/j.drudis.2020.03.019
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control (ECDC). (2021). SARS-CoV-2 variants of concern as of 21 May 2021. file:///C:/Users/ANT%C4%B0OKS%C4%B0DAN/Downloads/2_En_G%C3%BCncel_SARS-CoV-2%20variants%20of%20concern%20as%20of%2021%20May%202021.pdf
   Google Scholar
• Fernández, A. (2021). COVID-19 evolution in the post-vaccination phase: Endemic or extinct? ACS Pharmacology & Translational Science, 4, 403–405. https://doi.org/10.1021/acsptsci.0c00220
   PubMedGoogle Scholar
• Ferrareze, P. A. G., Franceschi, V. B., de Menezes Mayer, A., Caldana, G. D., Zimerman, R. A., & Thompson, C. E. (2021). E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil. bioRxiv. https://doi.org/10.1101/2021.01.27.426895
   Google Scholar
• Franceschi, V. B., Caldana, G. D., de Menezes Mayer, A., Cybis, G. B., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A. W., Weber, M. N., Fleck, J. D., Zimerman, R. A., Kmetzsch, L., Spilki, F. R., & Thompson, C. E. (2021). Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil. BMC Genomics, 22, 371. https://doi.org/10.1186/s12864-021-07708-w
   PubMed Web of Science ®Google Scholar
• Franceschi, V. B., Ferrareze, P. A. G., Zimerman, R. A., Cybis, G. B., & Thompson, C. E. (2021). Mutation hotspots, geographical and temporal distribution of SARS-CoV-2 lineages in Brazil, February 2020 to February 2021: Insights and limitations from uneven sequencing efforts. MedRxiv. https://doi.org/10.1101/2021.03.08.21253152
   Google Scholar
• Fratev, F. (2020). The N501Y and K417N mutations in the spike protein of SARS-CoV-2 alter the interactions with both hACE2 and human derived antibody: A Free energy of perturbation study. bioRxiv. https://doi.org/10.1101/2020.12.23.424283
   Google Scholar
• Ghorbani, M., Brooks, B. R., & Klauda, J. B. (2020). Critical sequence hotspots for binding of novel coronavirus to angiotensin converter enzyme as evaluated by molecular simulations. Journal of Physical Chemistry B, 124, 10034–10047. https://doi.org/10.1021/acs.jpcb.0c05994
   PubMed Web of Science ®Google Scholar
• Gobeil, S. M. C., Janowska, K., McDowell, S., Mansouri, K., Parks, R., Stalls, V., Kopp, M. F., Manne, K., Saunders, K., Edwards, R. J., Haynes, B. F., Henderson, R. C., & Acharya, P. (2021). Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicity. bioRxiv: the preprint server for biology. https://doi.org/10.1101/2021.03.11.435037.
   Google Scholar
• Harrison, C. (2020). Coronavirus puts drug repurposing on the fast track. Nature Biotechnology, 38, 379–381. https://doi.org/10.1038/d41587-020-00003-1
   PubMed Web of Science ®Google Scholar
• Hattori, T., Koide, A., Noval, M. G., Panchenko, T., Romero, L. A., Teng, K. W., Tada, T., Landau, N. R., Stapleford, K. A., & Koide, S. (2021). The ACE2-binding interface of SARS-CoV-2 spike inherently deflects immune recognition. Journal of Molecular Biology, 433, 166748. https://doi.org/10.1016/j.jmb.2020.166748
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Arora, P., Groß, R., Seidel, A., Hörnich, B. F., Hahn, A. S., Krüger, N., Graichen, L., Hofmann-Winkler, H., Kempf, A., Winkler, M. S., Schulz, S., Jäck, H.-M., Jahrsdörfer, B., Schrezenmeier, H., Müller, M., Kleger, A., Münch, J., & Pöhlmann, S. (2021). SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell, 184, 2384–2393.e12. https://doi.org/10.1016/j.cell.2021.03.036
   PubMed Web of Science ®Google Scholar
• Homeyer, N., & Gohlke, H. (2012). Free energy calculations by the molecular mechanics Poisson–Boltzmann surface area method. Molecular Informatics, 31, 114–122. https://doi.org/10.1002/minf.201100135
   PubMed Web of Science ®Google Scholar
• Hoover, W. G. (1985). Canonical dynamics: Equilibrium phase-space distributions. Physical Review A: Atomic, Molecular, and Optical Physics, 31, 1695–1697.
   PubMed Web of Science ®Google Scholar
• Hu, J., Peng, P., Wang, K., Liu, B.-z., Fang, L., Luo, F.-y., Jin, A.-s., Tang, N., & Huang, A. (2021). Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies. Cellular & Molecular Immunology, 18, 1061–1063.
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: visual molecular dynamics. Journal of Molecular Graphics, 14, 27–38. https://doi.org/10.1016/0263-7855(96)00018-5
   Google Scholar
• Idris, M. O., Yekeen, A. A., Alakanse, O. S., & Durojaye, O. A. (2020). Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches. Journal of Biomolecular Structure and Dynamics, 39, 5638–5656. https://doi.org/10.1080/07391102.2020.1792346
   PubMed Web of Science ®Google Scholar
• Jangra, S., Ye, C., Rathnasinghe, R., Stadlbauer, D., Personalized Virology Initiative study, g., Krammer, F., Simon, V., Martinez-Sobrido, L., Garcia-Sastre, A., & Schotsaert, M. (2021). SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe, 2, e283–e284. https://doi.org/10.1016/S2666-5247(21)00068-9
   PubMedGoogle Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. Journal of Chemical Physics, 79, 926–935. https://doi.org/10.1063/1.445869
   Web of Science ®Google Scholar
• Kastritis, P. L., Rodrigues, J. P., Folkers, G. E., Boelens, R., & Bonvin, A. M. (2014). Proteins feel more than they see: Fine-tuning of binding affinity by properties of the non-interacting surface. Journal of Molecular Biology, 426, 2632–2652. https://doi.org/10.1016/j.jmb.2014.04.017
   PubMed Web of Science ®Google Scholar
• Kemp, S. A., Datir, R. P., Collier, D. A., Ferreira, I. A. T. M., Carabelli, A., Harvey, W., Robertson, D. L., Gupta, & R. K., 2020. Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70, 15 December 2020 ed. bioRxiv.
   Google Scholar
• Krissinel, E., & Henrick, K. (2007). Inference of macromolecular assemblies from crystalline state. Journal of Molecular Biology, 372, 774–797. https://doi.org/10.1016/j.jmb.2007.05.022
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., Open Source Drug Discovery Consortium, & Lynn, A. (2014). g_mmpbsa – A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54, 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., & Wang, X. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581, 215–220. https://doi.org/10.1038/s41586-020-2180-5
   PubMed Web of Science ®Google Scholar
• Li, J., Hou, C., Wang, M., Liao, C., Guo, S., Shi, L., Ma, X., Zhang, H., Jiang, S., & Zheng, B. (2021). Hydrophobic interaction determines docking affinity of SARS CoV 2 variants with antibodies. arXiv preprint arXiv:2103.00399.
   Google Scholar
• Luan, J., Lu, Y., Jin, X., & Zhang, L. (2020). Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochemical and Biophysical Research Communications, 526, 165–169. https://doi.org/10.1016/j.bbrc.2020.03.047
   PubMed Web of Science ®Google Scholar
• Nelson, G., Buzko, O., Spilman, P., Niazi, K., Rabizadeh, S., & Soon-Shiong, P. (2021). Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant. bioRxiv 2021.2001.2013.426558. https://doi.org/10.1101/2021.01.13.426558
   Google Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52, 7182–7190. https://doi.org/10.1063/1.328693
   Web of Science ®Google Scholar
• Pedretti, A., Villa, L., & Vistoli, G. (2004). VEGA – An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. Journal of Computer-Aided Molecular Design, 18, 167–173. https://doi.org/10.1023/B:JCAM.0000035186.90683.f2
   PubMed Web of Science ®Google Scholar
• Qiao, B., & Olvera de la Cruz, M. (2020). Enhanced binding of SARS-CoV-2 spike protein to receptor by distal polybasic cleavage sites. ACS Nano, 14, 10616–10623. https://doi.org/10.1021/acsnano.0c04798
   PubMed Web of Science ®Google Scholar
• Rambaut, A., Loman, N., Pybus, O., Barclay, W., Barrett, J., Carabelli, A., Connor, T., Peacock, T., Robertson, D. L., & Volz, E. 2020. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological.org. https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563
   Google Scholar
• Riou, J., & Althaus, C. L. (2020). Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Eurosurveillance, 25, 2000058.
   Web of Science ®Google Scholar
• Sakkiah, S., Guo, W., Pan, B., Ji, Z., Yavas, G., Azevedo, M., Hawes, J., Patterson, T. A., & Hong, H. (2020). Elucidating interactions between SARS-CoV-2 trimeric spike protein and ACE2 using homology modeling and molecular dynamics simulations. Frontiers in Chemistry, 8, 622632.
   PubMed Web of Science ®Google Scholar
• Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020). Structural basis of receptor recognition by SARS-CoV-2. Nature, 581, 221–224. https://doi.org/10.1038/s41586-020-2179-y
   PubMed Web of Science ®Google Scholar
• Sharma, A., Tiwari, V., & Sowdhamini, R. (2020). Computational search for potential COVID-19 drugs from FDA-approved drugs and small molecules of natural origin identifies several anti-virals and plant products. Journal of Biosciences, 45, 1–18. https://doi.org/10.1007/s12038-020-00069-8
   PubMed Web of Science ®Google Scholar
• Shrake, A., & Rupley, J. A. (1973). Environment and exposure to solvent of protein atoms. Lysozyme and insulin. Journal of Molecular Biology, 79, 351–371. https://doi.org/10.1016/0022-2836(73)90011-9
   PubMed Web of Science ®Google Scholar
• Singh, T. U., Parida, S., Lingaraju, M. C., Kesavan, M., Kumar, D., & Singh, R. K. (2020). Drug repurposing approach to fight COVID-19. Pharmacological Reports, 72, 1479–1508. https://doi.org/10.1007/s43440-020-00155-6
   PubMed Web of Science ®Google Scholar
• Spinello, A., Saltalamacchia, A., & Magistrato, A. (2020). Is the rigidity of SARS-CoV-2 spike receptor-binding motif the hallmark for its enhanced infectivity? Insights from all-atom simulations. The Journal of Physical Chemistry Letters, 11, 4785–4790. https://doi.org/10.1021/acs.jpclett.0c01148
   PubMed Web of Science ®Google Scholar
• Starr, T. N., Greaney, A. J., Hilton, S. K., Crawford, K. H. D., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., Veesler, D., & Bloom, J. D. (2020). Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell, 182, 1295–1310. https://doi.org/10.1016/j.cell.2020.08.012
   PubMed Web of Science ®Google Scholar
• Team, E. E. (2021). Updated rapid risk assessment from ECDC on the risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA–First update. Eurosurveillance, 26, 2101211.
   Web of Science ®Google Scholar
• Tian, F., Tong, B., Sun, L., Shi, S., Zheng, B., Wang, Z., Dong, X., & Zheng, P. (2021). Mutation N501Y in RBD of spike protein strengthens the interaction between COVID-19 and its receptor ACE2. bioRxiv. https://doi.org/10.1101/2021.02.14.431117
   Google Scholar
• Verkhivker, G. M. (2020). Molecular simulations and network modeling reveal an allosteric signaling in the SARS-CoV-2 spike proteins. Journal of Proteome Research, 19, 4587–4608. https://doi.org/10.1021/acs.jproteome.0c00654
   PubMed Web of Science ®Google Scholar
• Verkhivker, G. M., & Di Paola, L. (2021). Dynamic network modeling of allosteric interactions and communication pathways in the SARS-CoV-2 spike trimer mutants: Differential modulation of conformational landscapes and signal transmission via cascades of regulatory switches. Journal of Physical Chemistry B, 125, 850–873. https://doi.org/10.1021/acs.jpcb.0c10637
   PubMed Web of Science ®Google Scholar
• Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 183, 1735. https://doi.org/10.1016/j.cell.2020.02.058
   PubMed Web of Science ®Google Scholar
• Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020). Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology, 94, e00127-20. https://doi.org/10.1128/JVI.00127-20
   PubMed Web of Science ®Google Scholar
• Wang, J., Xu, X., Zhou, X., Chen, P., Liang, H., Li, X., Zhong, W., & Hao, P. (2020). Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection. Journal of General Virology, 101, 921–924. https://doi.org/10.1099/jgv.0.001452
   PubMed Web of Science ®Google Scholar
• Wang, Y., Liu, M., & Gao, J. (2020). Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions. Proceedings of the National Academy of Sciences United States of America, 117, 13967–13974. https://doi.org/10.1073/pnas.2008209117
   PubMed Web of Science ®Google Scholar
• Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., Oliveira, T. Y., Yang, Z., Abernathy, M. E., Huey-Tubman, K. E., Hurley, A., Turroja, M., West, K. A., Gordon, K., Millard, K. G., … & Nussenzweig, M. C. (2021). mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature, 592, 616–622. https://doi.org/10.1038/s41586-021-03324-6
   PubMed Web of Science ®Google Scholar
• WHO. (2020). Coronavirus disease 2019 (COVID-19) situation report, p. 52. https://apps.who.int/iris/handle/10665/331476
   Google Scholar
• Wibmer, C. K., Ayres, F., Hermanus, T., Madzivhandila, M., Kgagudi, P., Oosthuysen, B., Lambson, B. E., de Oliveira, T., Vermeulen, M., van der Berg, K., Rossouw, T., Boswell, M., Ueckermann, V., Meiring, S., von Gottberg, A., Cohen, C., Morris, L., Bhiman, J. N., & Moore, P. L. (2021). SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nature Medicine, 27, 622–625. https://doi.org/10.1038/s41591-021-01285-x
   PubMed Web of Science ®Google Scholar
• Wise, J. (2021). Covid-19: The E484K mutation and the risks it poses. BMJ, 372, n359.
   PubMedGoogle Scholar
• Worldometer. (2020). Covid-19 coronavirus pandemic. Dadax Limited. https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?
   Google Scholar
• Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C. L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367, 1260–1263. https://doi.org/10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Xie, X., Liu, Y., Liu, J., Zhang, X., Zou, J., Fontes-Garfias, C. R., Xia, H., Swanson, K. A., Cutler, M., & Cooper, D. (2021). Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nature Medicine, 27, 620–621. https://doi.org/10.1038/s41591-021-01270-4
   PubMed Web of Science ®Google Scholar
• Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science, 367, 1444–1448. https://doi.org/10.1126/science.abb2762
   PubMed Web of Science ®Google Scholar
• Yi, C., Sun, X., Ye, J., Ding, L., Liu, M., Yang, Z., Lu, X., Zhang, Y., Ma, L., Gu, W., Qu, A., Xu, J., Shi, Z., Ling, Z., & Sun, B. (2020). Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cellular & Molecular Immunology, 17, 621–630.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., He, X., Man, V. H., Zhai, J., Ji, B., & Wang, J. (2021). Binding profile assessment of N501Y: A more infectious mutation on the receptor binding domain of SARS-CoV-2 spike protein. ChemRxiv. https://doi.org/10.26434/chemrxiv.13710961.v2
   Google Scholar